non clear cell renal carcinoma

Showing 1 - 2 of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Clear Cell Renal Carcinoma Trial in Guangzhou (Anlotinib plus Sintilimab)

Not yet recruiting
  • Non Clear Cell Renal Carcinoma
  • Anlotinib plus Sintilimab
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Feb 1, 2022

Carcinoma, Renal Cell, Non Clear Cell Renal Carcinoma Trial in Worldwide (RAD001)

Completed
  • Carcinoma
  • +4 more
  • Brussels, Belgium
  • +18 more
Jul 26, 2016